Biocatch

Snapshot

BioCatch is an Israeli fintech company founded in 2011 by Avi Turgeman and Uri Rivner. The company specializes in behavioral biometrics — technology that analyzes how users interact with digital devices (mouse movements, keystroke dynamics, smartphone grip angles) to detect fraud and verify identity.

Core Activity

BioCatch's primary product is a behavioral biometrics platform aimed primarily at banks and financial institutions. The platform monitors behavioral signals in real time as users perform actions such as logging in, transferring funds, or opening new accounts, and identifies anomalies that may indicate fraud, account takeover, or social engineering attacks. The primary buyers are retail banking organizations and fraud-prevention teams at large banks.

Market Position

BioCatch operates in the financial fraud detection space using behavioral biometrics — an approach that differentiates it from traditional identity verification providers relying on passwords, OTPs, or physical biometrics (fingerprints, facial recognition). In 2022, BioCatch completed a $100 million funding round led by Darwin Equity Partners, which valued the company at over one billion dollars and established it as a unicorn.

Israel Presence

BioCatch's R&D center is based in Tel Aviv. The founders, Avi Turgeman and Uri Rivner, are Israeli, and the company's core technical development has remained in Israel. BioCatch typically recruits in Israel for research, data science, and machine learning roles.

Company detailsActive

Open jobs by domain

Open jobs by domain

By seniority

Role mix

Posting timing

Questions & answers

Funding & deals

Role mix — current vs baseline

Seniority pyramid

Geographic split

Company intel & deep analysis

Snapshot

Core Activity

Market Position

Israel Presence

Key people & leadership

Interview prep for Biocatch

Office location

Open jobs right now

Recent news about the company

Hiring signal